FDA Warns Implant Device Makers Not To Use Purple Wristbands To Identify Implant Patients

Federal regulators are warning medical device manufacturers not to use purple wristbands or bracelets to alert medical staff that a patient has a particular implant, since that color is reserved to identify patients who do not want to be resuscitated, and use of the color may lead to confusion by medical providers.

A letter to medical device manufacturers was sent by the FDA last week, following a recent complaint indicating an unidentified medical device manufacturer was giving out purple wristbands to patients who had received a particular device. The letter urges device manufacturers not use the color purple, red or yellow to denote the presence of implants, since those colors are reserved for other uses.

Specific color coded hospital wristbands were standardized by the American Hospital Association (AHA) in 2008, which set the color purple to denote a patient’s “Do Not Resuscitate” (DNR) status. It also set the color red to denote a patient with allergies and the color yellow to identify patients who had a high risk of falling.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

However, the agency received a complaint recently that a medical device manufacturer was providing device identification bracelets which were also purple to denote the presence of their implant, which the agency warns could cause confusion for hospital staff who may mistake the wristband as a DNR status. To date, the FDA has no reports of any incidents linked to the bracelets being confused.

“The FDA is aware that purple hospital wristbands are given to patients in many health care settings to denote DNR status. The FDA is also aware other purple wristbands may have different meanings,” the letter states. “We encourage following AHA recommendations and reserve the use of purple bracelets or wristbands only for DNR status.”

The FDA recommends following the 2008 AHA recommendations for patients and using purple bracelets or wristbands only for DNR status. The agency also recommended manufactures be aware that a premarket submission is not needed to change the color of device identification patient bracelets or wristbands.

Manufacturers with questions can contact the Center for Devices and Radiological Health’s Division of Industry Communication and Education (DICE) at DICE@FDA.HHS.GOV, or by calling 800-638-2041, or 301-796-7100.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Silicosis Lawsuit Filed Against Artificial Stone Manufacturers, Distributors
Silicosis Lawsuit Filed Against Artificial Stone Manufacturers, Distributors (Posted today)

An artificial stone countertop fabricator and installer has filed a lawsuit after he developed a debilitating lung disease, known as silicosis, alleging that manufacturers failed to protect workers from inhaling dangerous amounts of silica dust.

BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal
BioZorb Lawsuit Indicates Recalled Tissue Marker Migrated After It Failed To Absorb, Resulting in Severe Pain and Surgical Removal (Posted 4 days ago)

Days after the FDA announced a BioZorb recall, an Arkansas woman has filed a lawsuit, indicating that her BioZorb tissue marker migrated out of position, causing pain and disfigurement, instead of harmlessly absorbing into the body as advertised.